Role of the Wilms' tumor gene WT1 in human leukemogenesis
Role of the Wilms' tumor gene WT1 in human leukemogenesis
批准号:
13470205
负责人:
SUGIYAMA Haruo
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. The wild-type WT1 gene is expressed in almost all leukemias and thus WT1mRNA is a pan-leukemia tumor marker.2. The growth of leukemia cells was inhabited by the treatment with WT1 antisense oligomers.3. Constitutive expression of the wild-type WT1 gene inhibited differentiation of 32D c13 myeloid progenitor cells and instead induced proliferation of the cells in response to G-CSF.4. Normal myeloid progenitor cells transfected with the wild-type WT1 cDNA-integrated retroviral vetcor formed more CFU-G, CFU-M, and CFU-GM colonies compared to those transfected with control vector in response to G-CSF.5. To determine the frequencies of WT1-expressing bone marrow cells, 1,632 CD34^+ human bone marrow progenitor cells were examined for the WT1 expression by using single-cell RT-PCR. Only 19 (1.2%) of the 1,632 CD34^+ cells expressed WT1mRMA and the WT1mRMA expression levels were similar between normal CD34^+ and leukemia single cells, suggesting that WT1-expressing CD34^+ cells were normal counterparts of WT1-expressing leukemia cells.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Li, H., et al.: "The Ick promoter-driven expression of the Wilms' tumor gene WT1 blocks intrathymic differentiation of T-lineage cells"International Journal of Hematology. (in press).
Li, H., 等人:“Wilms 肿瘤基因 WT1 的 Ick 启动子驱动的表达阻断了 T 谱系细胞的胸腺内分化”《国际血液学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugiyama, H.: "The wilms' tumor gene : its oncogenic function and clinical application"International Journal of Hematology. 73. 177-187 (2001)
Sugiyama, H.:“维尔姆斯肿瘤基因:其致癌功能和临床应用”国际血液学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hosen, N., et al.: "Very low frequencies of human normal CD34+ hematopoietic progenitor cells express the Wilms' tumor gene WT1 at the levels comaprable to those in leukemia cells"British Journal of Hematology.. 116. 409-420 (2002)
Hosen, N. 等人:“极低频率的人类正常 CD34 造血祖细胞以与白血病细胞相当的水平表达肾母细胞瘤基因 WT1”《英国血液学杂志》.. 116. 409-420 (2002
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hosen, N.: "Very low frequencies of human normal CD34^+ hematopoietic progenitor cells express the Wilms' tumor gene WT1 at the levels comaprable to those in leukemia cells"British Journal of Hematology. 116. 409-420 (2002)
Hosen,N.:“人类正常CD34+造血祖细胞以与白血病细胞相当的水平表达维尔姆斯肿瘤基因WT1的频率非常低”《英国血液学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ueda, T.: "Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas"Cancer Science. (in press).
Ueda, T.:“维尔姆斯肿瘤基因 WT1 在人骨和软组织肉瘤中的过度表达”癌症科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Development of molecular diagnosis and molecule-targeted therapy for leukemia
-
批准号:17015028
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$82.88万
-
财政年份:2005
-
负责人:SUGIYAMA Haruo
-
依托单位:
WT1 protein-targeted immunotherapy for leulemia
-
批准号:15109007
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$76.13万
-
财政年份:2003
-
负责人:SUGIYAMA Haruo
-
依托单位:
The role of the tumor suppressor gene WT1 in human leukemogenesis.
-
批准号:11470210
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.28万
-
财政年份:1999
-
负责人:SUGIYAMA Haruo
-
依托单位:
Analysis of roles of tumor suppressor gene WT1 in human leukemogenesis.
-
批准号:09470230
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.81万
-
财政年份:1997
-
负责人:SUGIYAMA Haruo
-
依托单位:
Role of the tumor suppressor gene WT1 in human leukemogenesis.
-
批准号:08457278
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.07万
-
财政年份:1996
-
负责人:SUGIYAMA Haruo
-
依托单位:
Analysis of the mechanisms of V_H gene selection in theformation of immunoglovulin heavy chain variable region genes.
-
批准号:62570212
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1987
-
负责人:SUGIYAMA Haruo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
-
批准号:82370711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:谢静远
-
依托单位:
ELL在前列腺癌发生中的负性作用机制及其临床意义
-
批准号:81101948
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:刘凌琪
-
依托单位:
PBX蛋白促肿瘤转移及VCP表达的调节作用研究
-
批准号:30801382
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:裘莹
-
依托单位:
肿瘤DNA低甲基化发生分子机理及其对白血病发病重要性的研究
-
批准号:30872933
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2008
-
负责人:张权庚
-
依托单位:
一个新型抗癌化合物对急性骨髓性白血病细胞Sin3A复合体的作用
-
批准号:30672422
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:张玉祥
-
依托单位:
人白血病干细胞与耐药性的关系研究
-
批准号:30572203
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2005
-
负责人:齐静
-
依托单位: